825 related articles for article (PubMed ID: 24557426)
1. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
4. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis.
Serefhanoglu K; Timurkaynak F; Can F; Cagir U; Arslan H; Ozdemir FN
J Formos Med Assoc; 2012 Jun; 111(6):325-32. PubMed ID: 22748623
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
7. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
Li Y; Du M; Chen LA; Liu Y; Liang Z
Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
[TBL] [Abstract][Full Text] [Related]
9. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.
Colombo AL; Guimarães T; Silva LR; de Almeida Monfardini LP; Cunha AK; Rady P; Alves T; Rosas RC
Infect Control Hosp Epidemiol; 2007 May; 28(5):570-6. PubMed ID: 17464917
[TBL] [Abstract][Full Text] [Related]
10. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
[TBL] [Abstract][Full Text] [Related]
11. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance.
Fernández-Ruiz M; Puig-Asensio M; Guinea J; Almirante B; Padilla B; Almela M; Díaz-Martín A; Rodríguez-Baño J; Cuenca-Estrella M; Aguado JM; ; ;
J Infect; 2015 Sep; 71(3):385-94. PubMed ID: 26033696
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.
Puig-Asensio M; Ruiz-Camps I; Fernández-Ruiz M; Aguado JM; Muñoz P; Valerio M; Delgado-Iribarren A; Merino P; Bereciartua E; Fortún J; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2015 May; 21(5):491.e1-10. PubMed ID: 25703212
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
[TBL] [Abstract][Full Text] [Related]
15. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
16. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
17. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
18. Incidence, characteristics and outcome of ICU-acquired candidemia in India.
Chakrabarti A; Sood P; Rudramurthy SM; Chen S; Kaur H; Capoor M; Chhina D; Rao R; Eshwara VK; Xess I; Kindo AJ; Umabala P; Savio J; Patel A; Ray U; Mohan S; Iyer R; Chander J; Arora A; Sardana R; Roy I; Appalaraju B; Sharma A; Shetty A; Khanna N; Marak R; Biswas S; Das S; Harish BN; Joshi S; Mendiratta D
Intensive Care Med; 2015 Feb; 41(2):285-95. PubMed ID: 25510301
[TBL] [Abstract][Full Text] [Related]
19. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.
Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Lepe-Jiménez JA
J Antimicrob Chemother; 2013 Jan; 68(1):206-13. PubMed ID: 22945914
[TBL] [Abstract][Full Text] [Related]
20. Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis.
González-Lara MF; Torres-González P; Cornejo-Juárez P; Velázquez-Acosta C; Martinez-Gamboa A; Rangel-Cordero A; Bobadilla-Del-Valle M; Ostrosky-Zeichner L; Ponce-de-León A; Sifuentes-Osornio J
BMC Infect Dis; 2017 Dec; 17(1):753. PubMed ID: 29212442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
